Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-4578PMID 16849537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An initial blueprint for myogenic differentiation.

  2005cited by this paper
• Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR

  2005influential reference
• The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

  2005cited by this paper
• RNA transcript profiling during zygotic gene activation in the preimplantation mouse embryo.

  2005cited by this paper
• EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.

  2005cited by this paper
• Genetic modeling of human rhabdomyosarcoma.

  2005cited by this paper
• MyoD and the transcriptional control of myogenesis.

  2005cited by this paper
• Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

  2004cited by this paper
• Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes.

  2004cited by this paper
• Gene Expression Signatures Identify Rhabdomyosarcoma Subtypes and Detect a Novel t(2;2)(q35;p23) Translocation Fusing PAX3 to NCOA1

  2004cited by this paper
• Sensitivity and specificity of five abundance estimators for high-density oligonucleotide microarrays

  2004cited by this paper
• Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.

  2004cited by this paper
• Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein

  2004cited by this paper
• Mammalian Sprouty4 Suppresses Ras-Independent ERK Activation by Binding to Raf1

  2003cited by this paper
• Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

  2003cited by this paper
• PAX3-FKHR Transformation Increases 26 S Proteasome-dependent Degradation of p27Kip1, a Potential Role for Elevated Skp2 Expression*

  2003cited by this paper
• PubMatrix: a tool for multiplex literature mining

  2003cited by this paper
• Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.

  2003cited by this paper
• Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1

  2003cited by this paper
• PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells

  2003cited by this paper
• Identifying biological themes within lists of genes with EASE

  2003cited by this paper
• Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.

  2002influential reference
• Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.

  2002influential reference
• Risk assignment in pediatric soft-tissue sarcomas: An evolving molecular classification

  2002cited by this paper
• Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.

  2002cited by this paper
• PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.

  2002influential reference
• Discordance between the Binding Affinity of Mitogen-activated Protein Kinase Subfamily Members for MAP Kinase Phosphatase-2 and Their Ability to Activate the Phosphatase Catalytically*

  2001cited by this paper
• IGFBP-3 and apoptosis—a licence to kill?

  2001cited by this paper
• Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma

  2001cited by this paper
• A Multiplex Real-Time PCR Assay for the Detection of Gene Fusions Observed in Solid Tumors

  2001cited by this paper
• PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.

  2001cited by this paper
• Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?

  2001cited by this paper
• Microarray Analysis Detects Novel Pax3 Downstream Target Genes* 210

  2001cited by this paper
• Control of muscle development by dueling HATs and HDACs.

  2001cited by this paper
• Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3.

  2001influential reference
• Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas

  2000cited by this paper
• Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

  2000cited by this paper
• Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma.

  2000cited by this paper
• Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt

  1999cited by this paper
• cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene

  1999influential reference
• Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.

  1999cited by this paper
• cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.

  1999cited by this paper
• Rhabdomyosarcoma – working out the pathways

  1999influential reference
• Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma.

  1998cited by this paper
• Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus

  1997cited by this paper
• Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue.

  1997cited by this paper
• Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

  1996cited by this paper
• Pax3 modulates expression of the c-Met receptor during limb muscle development.

  1996cited by this paper
• A license to kill.

  1996cited by this paper
• Fibroblast growth factor receptors display both common and distinct signaling pathways.

  1995cited by this paper
• The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.

  1995cited by this paper
• Biology and therapy of pediatric rhabdomyosarcoma.

  1995cited by this paper
• Pax3 Inhibits Myogenic Differentiation of Cultured Myoblast Cells (*)

  1995cited by this paper
• A transient three-plasmid expression system for the production of high titer retroviral vectors.

  1995cited by this paper
• Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification‐an intergroup rhabdomyosarcoma study

  1995cited by this paper
• Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.

  1995cited by this paper
• Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications

  1994cited by this paper
• Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis

  1994cited by this paper
• Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

  1993cited by this paper
• FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains.

  1992cited by this paper
• Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.

  1991cited by this paper
• The molecular basis of the undulated/Pax-1 mutation.

  1991cited by this paper
• Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.

  1990cited by this paper
• Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity

  1990cited by this paper

• Clinical management and therapeutic development for the rare disease rhabdomyosarcoma

  2026cites this paper
• Data set for reporting of paediatric rhabdomyosarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

  2025cites this paper
• Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS

  2025cites this paper
• Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls

  2025cites this paper
• PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma

  2025cites this paper
• Transcriptional regulation of genes by MYCN in PAX3::FOXO1-positive rhabdomyosarcomas and their roles in cell cycle progression

  2025cites this paper
• Histone deacetylase in human sarcomas

  2025cites this paper
• Revealing the role of increased SK3 expression in sulfonylurea resistance triggered by prolonged exposure

  2025cites this paper
• Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future

  2024cites this paper
• Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer

  2024cites this paper
• Aneuploidy and complex genomic rearrangements in cancer evolution

  2024cites this paper
• CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in an orthotopic mouse model

  2023cites this paper
• MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting

  2023cites this paper
• PAX–FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features

  2023cites this paper
• Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma

  2023cites this paper
• Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance

  2023influential citation
• Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation

  2023cites this paper
• CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

  2023cites this paper
• CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

  2023cites this paper
• Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies

  2023cites this paper
• Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3–FOXO1 in rhabdomyosarcoma

  2023cites this paper
• Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells

  2023cites this paper
• Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma

  2023cites this paper
• Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma

  2022influential citation
• Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma

  2022cites this paper
• Fusion-negative Rhabdomyosarcoma 3D-organoids as an innovative model to predict resistance to cell death inducers

  2022cites this paper
• Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma

  2022cites this paper
• Rhabdomyosarcomas are oncogene addicted to the activation of AVIL

  2022cites this paper
• Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

  2022cites this paper
• Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models

  2022cites this paper
• A GRIP-1–EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a

  2022cites this paper
• An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

  2022cites this paper
• K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications

  2022cites this paper
• Complex Elucidation of Cells-of-Origin in Pediatric Soft Tissue Sarcoma: From Concepts to Real Life, Hide-and-Seek through Epigenetic and Transcriptional Reprogramming

  2022cites this paper
• Anti-oncogenic and pro-myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma

  2022cites this paper
• Single-cell mapping of tumor heterogeneity in pediatric rhabdomyosarcoma reveals developmental signatures with therapeutic relevance

  2022cites this paper
• PROX1 transcription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets

  2022cites this paper
• The RNA helicase DDX5 cooperates with EHMT2 to sustain alveolar rhabdomyosarcoma growth.

  2022cites this paper
• Relapsed Rhabdomyosarcoma

  2021cites this paper
• Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020

  2021cites this paper
• Changes in FXR1 expression after Chemotherapy for Rhabdomyosarcoma.

  2021cites this paper
• Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm

  2021influential citation
• DCX and CRABP2 are candidate genes for differential diagnosis between pre‐chemotherapy embryonic and alveolar rhabdomyosarcoma in pediatric patients

  2021influential citation
• ACTA1 is inhibited by PAX3-FOXO1 through RhoA-MKL1-SRF signaling pathway and impairs cell proliferation, migration and tumor growth in Alveolar Rhabdomyosarcoma

  2021cites this paper
• Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs

  2021cites this paper
• Rhabdomyosarcoma—Updated Histologic and Molecular Classification for 2021

  2021cites this paper
• Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas

  2021cites this paper
• Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level

  2021cites this paper
• A Genome-Wide Association Study on Widespread Pain using the UK Biobank Cohort

  2021cites this paper
• FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas

  2021cites this paper
• FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.

  2021cites this paper
• The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition

  2020cites this paper
• Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

  2020influential citation
• Primary rhabdomyosarcoma: An extremely rare and aggressive variant of male breast cancer

  2020cites this paper
• Biopsy Techniques for Tumors

  2020cites this paper
• KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma

  2020influential citation
• Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner

  2020cites this paper
• SNAIL Promotes Metastatic Behavior of Rhabdomyosarcoma by Increasing EZRIN and AKT Expression and Regulating MicroRNA Networks

  2020influential citation
• Pediatric Solid Tumors

  2020cites this paper
• NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency

  2020cites this paper
• Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas

  2020cites this paper
• Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.

  2020cites this paper
• The PAXFOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition

  2020cites this paper
• OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.

  2020cites this paper
• PROX1 transcription factor is a master regulator of myogenic and oncogenic features of rhabdomyosarcoma

  2020cites this paper
• Signaling pathways in Rhabdomyosarcoma invasion and metastasis

  2020cites this paper
• The RNA helicase DDX5 promotes alveolar rhabdomyosarcoma growth and survival

  2020cites this paper
• Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.

  2019cites this paper
• Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma

  2019cites this paper
• [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].

  2019cites this paper
• The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486

  2019cites this paper
• OLIG2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcoma.

  2019cites this paper
• FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

  2019cites this paper
• MEK1/2 in Rhabdomyosarcoma

  2019cites this paper
• Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers

  2019cites this paper
• Rhabdomyosarcoma

  2019cites this paper
• Insights into pediatric rhabdomyosarcoma research: Challenges and goals

  2019cites this paper
• The expression and function of PAX3 in development and disease.

  2018cites this paper
• HNRNPH1 is required for rhabdomyosarcoma cell growth and survival

  2018cites this paper
• Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.

  2018cites this paper
• SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function

  2018cites this paper
• Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma

  2018influential citation
• Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma

  2018cites this paper
• Polo-like kinase 1 mediated phosphorylation regulates PAX3/FOXO1 in alveolar rhabdomyosarcoma

  2018cites this paper
• Sphingosine Induces Apoptosis and Down-regulation of MYCN in PAX3-FOXO1-positive Alveolar Rhabdomyosarcoma Cells Irrespective of TP53 Mutation.

  2018cites this paper
• Consensus and controversies regarding the treatment of rhabdomyosarcoma

  2018cites this paper
• EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma

  2017cites this paper
• Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements

  2017cites this paper
• PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.

  2017cites this paper
• Molecular profiling of sarcomas: new vistas for precision medicine

  2017cites this paper
• Size-based detection of sarcoma circulating tumor cells and cell clusters

  2017cites this paper
• The Use of Pediatric Patient-Derived Xenografts for Identifying Novel Agents and Combinations

  2017cites this paper
• NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma

  2017influential citation
• Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma

  2017cites this paper
• MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas

  2017influential citation
• Genomic Characterization of a Metastatic Alveolar Rhabdomyosarcoma Case Using FISH Studies and CGH+SNP Microarray Revealing FOXO1-PAX7 Rearrangement with MYCN and MDM2 Amplification and RB1 Region Loss

  2017cites this paper
• Title : PAX 3-FOXO 1 establishes myogenic super enhancers and confers BET bromodomain vulnerability

  2017cites this paper
• Patient-Derived Mouse Models of Cancer

  2017influential citation
• Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events

  2017cites this paper
• PAX3-FOXO1: Zooming in on an "undruggable" target.

  2017cites this paper